The ASPIRE trial encompasses a wide range of cancers, including breast cancer, lung cancer, colorectal cancer, and prostate cancer. By including multiple cancer types, the trial seeks to understand the broad applicability of the treatment combinations and identify specific patient subgroups that may benefit the most. Each cancer type is evaluated in separate cohorts to ensure the precision of results.
